09 Apr 2019

 MERZ NORTH AMERICA REGAINS EXCLUSIVE DISTRIBUTION OF ASCLERA (POLIDOCANOL) INJECTION

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able

0
08 Apr 2019

HIMSS conference speaker Will Present Lessons Learned from a HIPAA Audit

Carol Amick, manager of Healthcare Services, will speaking at the Healthcare Information and Management Systems Society Annual Conference to be held April 24-25 in Raleigh, North Carolina. Amick will discuss HIPAA regulations and how healthcare organizations are still missing the mark when it comes to covering the basics of HIPAA

0
02 Apr 2019

VIVA PHYSICIANS: ATTEND SVM19 IN MCLEAN, VA, MAY 29-JUNE 1

Register for the SVM 2019 Annual Scientific Sessions, the premier meeting for vascular medicine professionals. This year the meeting will take place in McLean, VA, at the Ritz-Carlton Tysons Corner, minutes from Washington, DC, May 29 – June 1. Early-bird registration rates end Monday, April 8. This is a very

0
28 Mar 2019

A NEW RF SYSTEM: VENCLOSE 2ND GENERATION RADIOFREQUENCY TECHNOLOGY OUTPERFORMS LEGACY SYSTEM

    By Larry Storer The great medical technology companies of our time start and develop in a variety of ways. Some start with a product or idea and built a market around it. Some start as spinoffs from existing successful companies. But Venclose started by determining the unmet needs

0
28 Mar 2019

SIGVARIS CHANGES CORPORATE NAME, LOGO

        SIGVARIS has changed its corporate name from SIGVARIS to SIGVARIS GROUP and has also changed its logo. SIGVARIS has a 150-year history of proven success, according to CEO Mark Bunker. “We are the world leader in medical compression socks and hosiery with a wide assortment of

0
28 Mar 2019

Virtual reality immerses physicians in AVLS education offerings

By Ron Seybold The American Vein and Lymphatic Society is launching a new project to use immersive virtual reality (VR) technology for its educational courses. The educational an array of venous medicine techniques. VR has started to make it possible to gain a better view than ever of fundamental and cutting-edge

0
28 Mar 2019

Covidien kickback scheme draws $17.4 million fine

Covidien LP, the developer and promoter of radiofrequency vein ablation, has agreed to pay $17,477,947 to resolve allegations that it violated the False Claims Act by providing free or discounted practice development and market development support to physicians located in California and Florida to induce purchases of Covidien’s vein ablation

0
28 Mar 2019

IAC research proposal deadline is April 15

  The IAC Research Committee seeks to support innoative and meritorious research relevant to accreditation and quality improvement through its annual IAC Research Award Program. Interested individuals are encouraged to submit proposals that advance the IAC Research Committee’s mission of “Strengthening Accreditation through Research.” Different for 2019, the IAC Research

0
28 Mar 2019

FDA evaluating stents, balloons with paclitaxel coating following JAHA evaluation

A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with an anti-inflammatory chemo agent called paclitaxel. “Further investigations are urgently

0
28 Mar 2019

Judge accepts Medtronic plea settling ev3 case

A federal judge in Boston accepted a plea deal from Medtronic neurovascular subsidiary ev3 in an off-label marketing case, according to court documents released at the end of January. U.S. Magistrate Judge Judith Dein granted the motion, which included the forfeiture of $6 million and an additional $11.9 million in

0